{
    "nctId": "NCT00784849",
    "briefTitle": "Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)",
    "officialTitle": "Pilot Trial to Determine the Feasibility of a One Step Sentinel Lymph Node Biopsy Procedure Using Radiolabeled Methylene Blue (IND 70,627)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 62,
    "primaryOutcomeMeasure": "The Number of Participants That Have Sentinel Nodes Which Are Radioactive or Blue, or Radioactive and Blue or Have Efferent Blue Lymphatics Leading up to the Sentinel Node(s)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Stage 0,I, II breast cancer\n* Clinical node status N0, N1\n* No know allergy to iodine, lymphazurin or methylene blue dyes\n\nExclusion Criteria:\n\n* Patient cannot be pregnant or nursing\n* Prisoners will not be eligible\n* Women under the age of 18 will not be eligible\n* Patients with a known allergy to iodine or methylene blue or lymphazurin blue dyes",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}